Guillain-Barré syndrome as a complication of hypertensive basal ganglia haemorrhage

J Clin Neurosci. 2019 Jun:64:54-56. doi: 10.1016/j.jocn.2019.02.018. Epub 2019 Mar 6.

Abstract

We aimed to study the potential relationship of Guillain-Barré syndrome (GBS) and intracranial haemorrhage (ICH). We present a case of a 70-year-old hypertensive woman who developed global weakness, eventually becoming quadriplegic, during an inpatient stay for treatment of a basal ganglia haemorrhagic stroke. Guillain-Barré syndrome was confirmed and treatment initiated. She responded well to intravenous immunoglobulin treatment and then subsequently continued with rehabilitation. There have been a few case reports of GBS as a complication of spontaneous intracranial haemorrhage (ICH) or traumatic brain injury. It may not be a coincidence that our patient developed GBS shortly after presentation. There may be an immunological explanation with immune activation following neuronal injury after ICH with associated blood-brain barrier breakdown. GBS following ICH adds further complexity to treating patients who are already critically ill. If patients develop new weakness after ICH, there should be a high index of suspicion for GBS. It should be distinguished from critical illness neuropathy/myopathy and other causes of weakness in critical care patients because the treatment is very different. Immune activation and sensitization to myelin-associated proteins may be the underlying pathophysiological basis.

Keywords: AIDP; Acute inflammatory demyelinating polyradiculoneuropathy; Guillain-Barré syndrome; Hypertensive intracranial haemorrhage.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Basal Ganglia Hemorrhage / complications*
  • Female
  • Guillain-Barre Syndrome / drug therapy
  • Guillain-Barre Syndrome / etiology*
  • Guillain-Barre Syndrome / physiopathology
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use

Substances

  • Immunoglobulins, Intravenous